Anastrozole: all 149 studies that test it
Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesRecruitingNCT07604272Phase 1
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNCT07568574Not applicable
- A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 InhibitorsNot yet recruitingNCT07163481Phase 1
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruitingNCT06492616Phase 3
- Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerRecruitingNCT06380751Phase 3
- Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast CancerNot yet recruitingNCT06223698Phase 3
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingNCT06075953Phase 2
- NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast CancerRecruitingNCT05837455Phase 2
- Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyEnrolling by invitationNCT05645536Phase 3
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingNCT05586802Phase 3
- Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerRecruitingNCT05524584Phase 2
- ETHAN - ET for Male BCRecruitingNCT05501704Phase 2
- Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituRecruitingNCT04666961Phase 2
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerRecruitingNCT04553770Phase 2
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreRecruitingNCT02476786Phase 2
- Brain Blood Flow Responses to Stress: Sex DifferencesCompletedNCT06253702Phase 4Results posted
- Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial CancerCompletedNCT04719273Phase 2Results posted
- Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerCompletedNCT04294225Phase 2Results posted
- A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to ProgesteroneCompletedNCT03909152Phase 2Results posted
- Aromatase Inhibitors and Weight Loss in Severely Obese Men With HypogonadismCompletedNCT03490513Phase 4Results posted
- Pulmonary Hypertension and Anastrozole TrialCompletedNCT03229499Phase 2Results posted
- Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast CancerCompletedNCT03219476Phase 2Results posted
- Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)CompletedNCT02959853Phase 4Results posted
- A Study of Abemaciclib (LY2835219) in Participants With Breast CancerActive, not recruitingNCT02763566Phase 3Results posted
- A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT02441946Phase 2Results posted
- Endocrine Response in Women With Invasive Lobular Breast CancerCompletedNCT02206984Phase 2Results posted
- Bay98-7196, Dose Finding / POC StudyCompletedNCT02203331Phase 2Results posted
- ER Reactivation Therapy for Breast CancerCompletedNCT02188745Phase 2Results posted
- S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast CancerTerminatedNCT02137837Phase 3Results posted
- Aromatase Inhibitor Growth Study: Letrozole vs. AnastrozoleCompletedNCT02137538Phase 4Results posted
- GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese PatientsTerminatedNCT02095184Not applicableResults posted
- To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid CancerCompletedNCT02093351Phase 1Results posted
- A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)Active, not recruitingNCT01824836Not applicableResults posted
- Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast CancerTerminatedNCT01776008Phase 2Results posted
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerActive, not recruitingNCT01723774Phase 2Results posted
- Anastrozole in Patients With Pulmonary Arterial HypertensionCompletedNCT01545336Phase 2Results posted
- Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerTerminatedNCT01394211Phase 2Results posted
- Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTerminatedNCT01234532Phase 2Results posted
- ITT4 Intratesticular Hormonal Milieu in Man (ITT4)CompletedNCT01215292Phase 1/2Results posted
- Anastrozole 1 mg Tablets Under Fed ConditionsCompletedNCT01183390Phase 1Results posted
- Anastrozole 1 mg Tablets Under Fasting ConditionsCompletedNCT01182181Phase 1Results posted
- Pre-Surgical Intervention for Targeted Therapies for Breast CancerCompletedNCT01004744Not applicableResults posted
- Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung CancerTerminatedNCT00932152Phase 2Results posted
- Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.CompletedNCT00921115Phase 2Results posted
- CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in MenCompletedNCT00729859Phase 2Results posted
- Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine TherapyTerminatedNCT00661531Phase 2Results posted
- Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsCompletedNCT00612560Not applicableResults posted
- Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal TreatmentCompletedNCT00605267Phase 3Results posted
- Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureTerminatedNCT00555477Phase 2Results posted
- Liver Safety Under Upfront Arimidex vs TamoxifenCompletedNCT00537771Phase 4Results posted
- Aromatase Inhibitors in the Treatment of Male InfertilityTerminatedNCT00440180Phase 3Results posted
- Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast CancerCompletedNCT00405938Phase 2Results posted
- Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast CancerCompletedNCT00354640Phase 2Results posted
- Arthralgia During Anastrozole Therapy for Breast CancerCompletedNCT00323479Phase 4Results posted
- Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic AcidCompletedNCT00295646Phase 3Results posted
- Secondary Adjuvant Long Term Study With ArimidexCompletedNCT00295620Phase 3Results posted
- Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00265759Phase 3Results posted
- Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast CancerCompletedNCT00259090Phase 2Results posted
- Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal WomenCompletedNCT00256217Phase 2Results posted
- Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase InhibitorsCompletedNCT00253422Phase 3Results posted
- Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00217399Phase 1/2Results posted
- Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory DysfunctionCompletedNCT00213148Phase 2Results posted
- Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal WomenCompletedNCT00186121Phase 2Results posted
- Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or PlaceboCompletedNCT00179517Phase 2Results posted
- Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast CancerCompletedNCT00143390Phase 3Results posted
- Anastrozole Administration in Elderly Hypogonadal MenCompletedNCT00136695Phase 2Results posted
- Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.CompletedNCT00104572Phase 2Results posted
- Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]CompletedNCT00094328Phase 2Results posted
- Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In SituCompletedNCT00072462Phase 3Results posted
- Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerCompletedNCT00057941Phase 2Results posted
- Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation TherapyCompletedNCT00053898Phase 3Results posted
- Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast CancerActive, not recruitingNCT05826964Phase 2
- Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancerActive, not recruitingNCT05780567Phase 3
- A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast CancerActive, not recruitingNCT05257395Phase 3
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedNCT05150652Phase 2
- Study of Exposure to Substances Prohibited by the World Anti-Doping Agency in Healthy Volunteers.CompletedNCT04757532Phase 1
- A Phase I/II Study of XZP-3287 in Metastasis Solid TumorsActive, not recruitingNCT04539496Phase 1/2
- Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed ConditionStatus unknownNCT04445922Phase 1
- Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fasted ConditionStatus unknownNCT04438733Phase 1
- A Study of Neoadjuvant SHR6390 in Combination With Anastrozole, Pyrotinib, and Trastuzumab in Patients With ER+/HER2+ Breast Cancer.Status unknownNCT04236310Phase 2
- Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.Active, not recruitingNCT03616587Phase 1
- Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastActive, not recruitingNCT03304080Phase 1/2
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer PatientsCompletedNCT02995772Phase 3
- Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast CancerActive, not recruitingNCT02942355Phase 2
- Cardiovascular Outcomes of Low TestosteroneCompletedNCT02758431Not applicable
- Open-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleTerminatedNCT02476955Phase 1
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownNCT02097459Phase 3
- Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownNCT02089854Phase 4
- The Study of Goserelin Plus Fulvestrant Comparing With Goserelin Plus Anastrozole for Advanced Breast CancerStatus unknownNCT02072512Phase 2
- Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer PatientsCompletedNCT01972984Phase 2
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 3
- Impact of Estradiol AddbackCompletedNCT01862835Phase 1
- Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis RecurrenceCompletedNCT01769781Phase 4
- Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt LoadingWithdrawnNCT01763541Early Phase 1
- Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast CancerCompletedNCT01612871Phase 4
- Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male SubjectsCompletedNCT01568281Phase 1
- Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or NotCompletedNCT01553903Phase 4
- Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi SyndromeStatus unknownNCT01520467Not applicable